We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. The Administrator of personal data is STOCKTRADEIQ sp. z o.o., with its registered office in Poznan (61-625), at the following address: Czarna Rola 30 Street. Cookies policy here. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

  • Cookie
    cookieyes-consent
  • Duration
    1 year
  • Description
    CookieYes sets this cookie to remember users' consent preferences so that their preferences are respected on their subsequent visits to this site. It does not collect or store any personal information of the site visitors.
  • Cookie
    x-ms-cpim-csrf
  • Duration
    session
  • Description

    Inter-site request forgery token used to protect crSF. For more information, read the section Token falsification of requests between sites.

  • Cookie
    x-ms-cpim-sso:stocktradeiqauth.onmicrosoft.com_0
  • Duration
    session
  • Description

    Used to support single sign-on sessions. This cookie is set as persistent when the Keep me logged in option is enabled.

  • Cookie
    server-telemetry-{id}
  • Duration
    persistent
  • Description

    A value used by Microsoft for authorisation and authentication.

  • Cookie
    google_auto_fc_cmp_setting
  • Duration
    persistent
  • Description


    Stores the state of the User cookie for the current domain.

     

  • Cookie
    {id}-https://stocktradeiqauth.onmicrosoft.com/{id}
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    msal{id}.active-account
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-refreshtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com-idtoken
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    {id}signinup{id}stocktradeiqauth.b2clogin.com
  • Duration
    persistent
  • Description

    Stores information about the logged-in user's session.

  • Cookie
    Microsoft Clarity
  • Duration
    1 year
  • Description

    Microsoft Clarity

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

  • Cookie
    isLightMode
  • Duration
    1 year
  • Description

    Defines the UI theme

  • Cookie
    userCultureData
  • Duration
    persistent
  • Description

     Stores information about the user's machine culture.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

  • Cookie
    _ga
  • Duration
    1 year 1 month 4 days
  • Description
    The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
  • Cookie
    _ga_*
  • Duration
    1 year 1 month 4 days
  • Description
    Google Analytics sets this cookie to store and count page views.
  • Cookie
    hotjar
  • Duration
    1 year 1 month 4 days
  • Description

    Analyzing users' behaviour in the website

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

  • Cookie
    __gpi
  • Duration
    1 year 24 days
  • Description
    Google Ads Service uses this cookie to collect information about from multiple websites for retargeting ads.
  • Cookie
    __gads
  • Duration
    1 year 24 days
  • Description

    The file, set by Google, is stored in the DoubleClick domain and tracks the number of times users view an ad, measures the success of the campaign and calculates its revenue. This cookie can only be read from the domain where it is set and does not track any data when browsing other sites.

  • Cookie
    goog:cached:topics
  • Duration
    persistent
  • Description

    It is used to record which adverts have been displayed to the User.

  • Cookie
    IDE
  • Duration
    year
  • Description

    Used by Google DoubleClick to record and report on the Website User's actions after viewing or clicking on an advertiser's ads in order to measure the effectiveness of the ad and present the User with targeted advertising.

  • Cookie
    google_experiment_mod44
  • Duration
    persistent
  • Description

    Used by Google Ad to experiment with the effectiveness of ads on websites using their services.

Powered by Cookieyes logo

    Get Diamond plan for FREE

    logo

    Cardio Diagnostics Holdings, Inc. (CDIO)

    Price:

    3.67 USD

    ( - -0.03 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    CDIO
    Name
    Cardio Diagnostics Holdings, Inc.
    Industry
    Biotechnology
    Sector
    Healthcare
    Price
    3.670
    Market Cap
    6.702M
    Enterprise value
    732.969M
    Currency
    USD
    Ceo
    Meeshanthini V. Dogan
    Full Time Employees
    13
    Website
    cardiodiagnosticsinc.com
    Ipo Date
    2022-01-14
    City
    Chicago
    Address
    400 N Aberdeen St

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Regeneron Pharmaceuticals, Inc.

    VALUE SCORE:

    6

    Symbol
    REGN
    Market Cap
    76.562B
    Industry
    Biotechnology
    Sector
    Healthcare

    2nd position

    ADMA Biologics, Inc.

    VALUE SCORE:

    11

    Symbol
    ADMA
    Market Cap
    4.706B
    Industry
    Biotechnology
    Sector
    Healthcare

    The best

    Genmab A/S

    VALUE SCORE:

    11

    Symbol
    GMAB
    Market Cap
    122.616B
    Industry
    Biotechnology
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -1.021
    P/S
    343.549
    P/B
    0.656
    Debt/Equity
    0.056
    EV/FCF
    0.127
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    -36.831
    Earnings yield
    -0.979
    Debt/assets
    0.053
    FUNDAMENTALS
    Net debt/ebidta
    1.249
    Interest coverage
    -380.462
    Research And Developement To Revenue
    1.050
    Intangile to total assets
    0.068
    Capex to operating cash flow
    -0.029
    Capex to revenue
    8.082
    Capex to depreciation
    0.478
    Return on tangible assets
    -0.645
    Debt to market cap
    0.082
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    0.032
    P/CF
    -1.156
    P/FCF
    -1.180
    RoA %
    -60.117
    RoIC %
    -60.700
    Gross Profit Margin %
    -356.980
    Quick Ratio
    23.548
    Current Ratio
    23.548
    Net Profit Margin %
    -32.040k
    Net-Net
    4.200
    FUNDAMENTALS PER SHARE
    FCF per share
    -3.266
    Revenue per share
    0.011
    Net income per share
    -3.594
    Operating cash flow per share
    -3.175
    Free cash flow per share
    -3.266
    Cash per share
    4.581
    Book value per share
    5.592
    Tangible book value per share
    5.183
    Shareholders equity per share
    5.592
    Interest debt per share
    0.324
    TECHNICAL
    52 weeks high
    42.600
    52 weeks low
    2.424
    Current trading session High
    3.670
    Current trading session Low
    3.340
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.816
    logo
    Country
    CH
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.776
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -1.081k
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.568
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.971
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.154
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.246
    logo
    Country
    IL
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.587
    logo
    Country
    AU
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    0
    logo
    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.316k
    DESCRIPTION

    Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

    NEWS
    https://images.financialmodelingprep.com/news/cardio-diagnostics-receives-final-gapfill-payment-rates-for-aidriven-20251203.jpg
    Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

    businesswire.com

    2025-12-03 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that CMS has issued a final gapfill payment rate of $854 for both the Epi+Gen CHD™ and PrecisionCHD™ tests.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-to-present-data-demonstrating-precisionchds-20251105.jpg
    Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD's Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions

    businesswire.com

    2025-11-05 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will be presenting new data at the American Heart Association (AHA) Scientific Sessions.

    https://images.financialmodelingprep.com/news/nch-becomes-first-us-hospital-to-use-ai-that-detects-20251105.jpg
    NCH Becomes First U.S. Hospital to Use AI That Detects Hidden Heart Attack Risk a Decade in Advance

    prnewswire.com

    2025-11-05 07:00:00

    /PRNewswire/ -- Naples Comprehensive Health (NCH) and Caristo Diagnostics announced that NCH Rooney Heart Institute has become the first hospital in the nation

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-and-ymca-of-east-tennessee-20251028.jpg
    Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community

    businesswire.com

    2025-10-28 08:35:00

    KNOXVILLE, Tenn. & CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced they are partnering with YMCA of East Tennessee to launch a customized program exclusively for its members.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-expands-provider-network-adding-15-new-20251021.jpg
    Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States

    businesswire.com

    2025-10-21 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. today announced the Company has partnered with 15 new provider organizations across the United States.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-receives-gapfill-payment-rates-for-aidriven-cardiovascular-20250722.jpg
    Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

    businesswire.com

    2025-07-22 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics CMS has issued preliminary gapfill payment rates of $350 for Epi+Gen CHD™ and $684.76 for PrecisionCHD™.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-enters-into-an-agreement-with-agepha-pharma-to-20250708.jpg
    Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

    businesswire.com

    2025-07-08 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced an agreement with AGEPHA Pharma.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-secures-japanese-patent-for-aidriven-cardiovascular-disease-detection-20250610.jpg
    Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

    businesswire.com

    2025-06-10 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that the Japan Patent Office has issued a patent for another set of biomarkers in the company's IP portfolio.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-regains-compliance-with-nasdaq-minimum-20250529.jpg
    Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

    businesswire.com

    2025-05-29 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics today announced it has regained compliance with Nasdaq minimum bid price.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-broadens-access-to-precision-cardiovascular-care-with-20250520.jpg
    Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

    businesswire.com

    2025-05-20 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has the continued expansion of its reach with a new cohort of healthcare practices across the United States.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-announces-1for30-reverse-stock-split-20250508.jpg
    Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

    businesswire.com

    2025-05-08 08:35:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-to-showcase-enhanced-precisionchd-actionable-20250326.jpg
    Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

    businesswire.com

    2025-03-26 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will showcase its growing portfolio of advanced cardiovascular solutions at the ACC's 74th Annual Scientific Session & Expo.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-expands-the-reach-of-its-aidriven-precision-20250204.jpg
    Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

    businesswire.com

    2025-02-04 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics has announced that the Company has partnered with seven new provider organizations.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-receives-final-medicare-pricing-determination-20241216.jpg
    Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

    businesswire.com

    2024-12-16 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced their PrecisionCHD and Epi+Gen CHD tests have received final pricing determinations from CMS.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-holdings-inc-receives-preliminary-medicare-pricing-from-20241001.jpg
    Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

    businesswire.com

    2024-10-01 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics' PrecisionCHD and Epi+Gen CHD tests have received preliminary pricing determinations from CMS.

    https://images.financialmodelingprep.com/news/cardio-diagnostics-announces-its-exhibiting-at-the-2024-onsite-20240625.jpg
    Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum

    businesswire.com

    2024-06-25 08:31:00

    CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum.